» Articles » PMID: 27785616

PEPCK-C Reexpression in the Liver Counters Neonatal Hypoglycemia in Pck1 Mice, Unmasking Role in Non-gluconeogenic Tissues

Overview
Specialties Biochemistry
Physiology
Date 2016 Oct 28
PMID 27785616
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Whole body cytosolic phosphoenolpyruvate carboxykinase knockout (PEPCK-C KO) mice die early after birth with profound hypoglycemia therefore masking the role of PEPCK-C in adult, non-gluconeogenic tissues where it is expressed. To investigate whether PEPCK-C deletion in the liver was critically responsible for the hypoglycemic phenotype, we reexpress this enzyme in the liver of PEPCK-C KO pups by early postnatal administration of PEPCK-C-expressing adenovirus. This maneuver was sufficient to partially rescue hypoglycemia and allow the pups to survive and identifies the liver as a critical organ, and hypoglycemia as the critical pathomechanism, leading to early postnatal death in the whole-body PEPCK-C knockout mice. Pathology assessment of survivors also suggest a possible role for PEPCK-C in lung maturation and muscle metabolism.

Citing Articles

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.

Namiki T, Takemoto M, Hayashi A, Yamagata H, Ishikawa T, Yokote K BMC Endocr Disord. 2023; 23(1):239.

PMID: 37904164 PMC: 10614393. DOI: 10.1186/s12902-023-01491-3.


PCK1 dysregulation in cancer: Metabolic reprogramming, oncogenic activation, and therapeutic opportunities.

Xiang J, Wang K, Tang N Genes Dis. 2023; 10(1):101-112.

PMID: 37013052 PMC: 10066343. DOI: 10.1016/j.gendis.2022.02.010.


Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming.

Chen H, Li L, Du Y Front Pharmacol. 2023; 14:1115226.

PMID: 36937859 PMC: 10017497. DOI: 10.3389/fphar.2023.1115226.


Transcriptomics and Lipid Metabolomics Analysis of Subcutaneous, Visceral, and Abdominal Adipose Tissues of Beef Cattle.

Du L, Chang T, An B, Liang M, Deng T, Li K Genes (Basel). 2023; 14(1).

PMID: 36672778 PMC: 9858949. DOI: 10.3390/genes14010037.


Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Rodgers R Physiol Rep. 2022; 10(9):e15263.

PMID: 35569125 PMC: 9107925. DOI: 10.14814/phy2.15263.


References
1.
Yang J, Kalhan S, Hanson R . What is the metabolic role of phosphoenolpyruvate carboxykinase?. J Biol Chem. 2009; 284(40):27025-9. PMC: 2785631. DOI: 10.1074/jbc.R109.040543. View

2.
Mendez-Lucas A, Duarte J, Sunny N, Satapati S, He T, Fu X . PEPCK-M expression in mouse liver potentiates, not replaces, PEPCK-C mediated gluconeogenesis. J Hepatol. 2013; 59(1):105-13. PMC: 3910155. DOI: 10.1016/j.jhep.2013.02.020. View

3.
Mendez-Lucas A, Hyrossova P, Novellasdemunt L, Vinals F, Perales J . Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability. J Biol Chem. 2014; 289(32):22090-102. PMC: 4139223. DOI: 10.1074/jbc.M114.566927. View

4.
Lei K, Chen H, Pan C, Ward J, Mosinger Jr B, Lee E . Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet. 1996; 13(2):203-9. DOI: 10.1038/ng0696-203. View

5.
Torday J, Rehan V . Neutral lipid trafficking regulates alveolar type II cell surfactant phospholipid and surfactant protein expression. Exp Lung Res. 2011; 37(6):376-86. DOI: 10.3109/01902148.2011.580903. View